Navigation Links
Dan Renick, RPh, Joins The Hobart Group as Managing Partner

Strengthens firm's ability to drive clients' success in managed care

GLADSTONE, N.J., May 28 /PRNewswire/ -- The Hobart Group, a full-service managed market agency focused on securing formulary access for today's pharmaceutical brands, announces the addition of Dan Renick, RPh, as Managing Partner. Renick will provide strategic counsel to The Hobart Group's pharmaceutical and biotech clients, including GlaxoSmithKline, sanofi-aventis, and Forest Laboratories.

"Dan brings a unique managed care perspective to The Hobart Group and our clients," said Lisa B. Bair, President. "His knowledge of what matters to payers during the formulary decision process, in particular, Medicare Part D, will help address a critical need for our clients."

"There is more pressure than ever on drugmakers to maximize revenues of their key assets. In today's market, it's critical that companies are able to effectively differentiate their drugs from the competition," said Renick. "I'm excited to apply my knowledge of what payers are looking for with our clients. As the healthcare environment evolves, it is critical to provide our managed market customers with strategies that deliver innovative solutions to obtaining formulary access."

Prior to joining The Hobart Group, Renick served as Director, Corporate Pharmacy Management, at Humana Inc., a national managed care organization with more than 11 million members and the second largest Medicare Part D and Medicare Advantage sponsor. In this role, Renick was responsible for Pharmacy Programs and trade relations, including contracting oversight with both pharmaceutical companies and pharmacy provider organizations. At Merck & Co., Inc., Renick worked with large employers, business coalitions, and benefits consultants in support of rational and evidence-based benefit-design decisions.

In addition, he has worked with various other managed market segments with an emphasis on Senior Care, and spent several years in pharmacy operations at the regional and headquarters level for both retail and long-term care pharmacy providers. Renick earned his RPh degree from the University of Kentucky and his BS degree in chemistry and biology from Western Kentucky University.

About The Hobart Group

The Hobart Group is a full-service managed market agency providing specialized services aimed at obtaining formulary access. The Hobart Group has developed a full suite of technology tools to help enhance relationships with payer customers. For more information about The Hobart Group, visit

SOURCE The Hobart Group
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
3. Hank Plain Joins Morgenthaler Ventures as Partner
4. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
5. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
6. Dan Broderick Joins Prolog Ventures as Partner
7. Ingenuity Systems Joins Biomarkers Consortium
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
10. Progeniq Joins Microsoft in Bio IT Alliance
11. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
Post Your Comments:
(Date:11/24/2015)... ... 24, 2015 , ... The Academy of Model Aeronautics (AMA), led by its ... as Multirotor Grand Prix, to represent the First–Person View (FPV) racing community. , FPV ... embraced this type of racing and several new model aviation pilots have joined the ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... 11,000 post-share consolidation (or 1,100,000 pre-share consolidation) Series ... Warrants") subject to the previously disclosed November 1, ... which will result in the issuance of 365,518 ... issuance of such shares, there will be approximately ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Inc., on being named to Deloitte's 2015 Technology Fast 500 list of the ... manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up orthodontic tooth ...
(Date:11/24/2015)... 24, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... company,s president and chief executive officer, will present at the ... in New York City . The presentation ... 1, 2015 at 9:30 a.m. EST. ... website at least 15 minutes prior to the presentation to ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
Breaking Biology News(10 mins):